A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17

Brain

Volumn 129, Issue 4, 2006, Pages 853-867

  Mackenzie, Ian R ^a   Baker, Matthew ^d   West, Gemma ^d   Woulfe, John ^b   Qadi, Najeeb ^a   Gass, Jennifer ^d   Cannon, Ashley ^d   Adamson, Jennifer ^d   Feldman, Howard ^a   Lindholm, Caroline ^a   Melquist, Stacey ^d   Pettman, Rachel ^c   Sadovnick, A Dessa ^a   Dwosh, Emily ^a   Whiteheart, Sidney W ^e   Hutton, Michael ^d   Pickering Brown, Stuart M ^f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c IWK HEALTH CENTRE   (Canada)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Frontotemporal dementia; Linkage analysis; Neuronal intranuclear inclusions; Ubiquitin

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN; SUMO 1 PROTEIN; TAU PROTEIN;

ADULT; AGED; ARTICLE; AUTOPSY; AUTOSOMAL DOMINANT INHERITANCE; CELL INCLUSION; CELL NUCLEUS INCLUSION BODY; CHROMOSOME 17; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FRONTOTEMPORAL DEMENTIA; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUTATION; NERVE DEGENERATION; NEUROPATHOLOGY; POINT MUTATION; PRIORITY JOURNAL; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CHROMOSOMES, HUMAN, PAIR 17; DEMENTIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTRANUCLEAR INCLUSION BODIES; LINKAGE (GENETICS); MALE; MIDDLE AGED; NEURONS; PEDIGREE; TAU PROTEINS; UBIQUITIN;

EID: 33645072728     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awh724     Document Type: Article

References (42)

1. Benussi L, Signorini S, Ghidoni R, Alberici A, Barbiero L, Feudatari E, et al. Identification of genetic loci associated with familial frontotemporal dementia. Neurobiol Aging 2004; 25: S517-8.
2. Bigio EH, Johnson NA, Rademaker AW, Fung BB, Mesulam MM, Siddique N, et al. Neuronal ubiquitinated intranuclear inclusions in familial and non-familial frontotemporal dementia of the motor neuron disease type associated with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2004; 63: 801-11.
3. Bird TD, Wijsman EM, Nochlin D, Leehey M, Sumi SM, Payami H, et al. Chromosome 17 and hereditary dementia: linkage studies in three non-Alzheimer families and kindreds with late-onset FAD. Neurology 1997; 48: 949-54.
4. Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 2001; 27: 117-20.
5. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994; 124 (Suppl): 96-107.
6. Brun A, Englund E, Gustafson L, Passant U, Mann DM, Neary D, et al. Clinical, neuropsychological and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatr 1994; 57: 416-8.
7. Chai Y, Koppenhafer SL, Bonini NM, Paulson HL. Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease. J Neurosci 1999; 19: 10338-47.
8. Davies SW, Beardsall K, Turmaine M, DiFiglia M, Aronin N, Bates GP. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine expansions? Lancet 1998; 351: 131-3.
9. Froelich Fabre S, Axelman P, Almkvist A, Basun H, Lannfelt L. Extended investigation of tau and mutation screening of other candidate genes on chromosome 17q21 in a Swedish FTDP-17 family. Am J Med Genet B Neuropsychiatr Genet 2003; 121: 112-8.
10. Haltia M, Somer H, Palo J, Johnson WG. Neuronal intranuclear inclusion disease in identical twins. Ann Neurol 1984; 15: 316-21.
11. Hutton M, Lendon C, Rizzu P, Baker M, Froelich S, Houlden H, et al. Coding and 5′ splice mutations in tau associated with inherited dementia (FTDP-17). Nature 1998; 393: 702-5.
12. Jackson M, Lennox G, Lowe J. Motor neurone disease-inclusion dementia. Neurodegeneration 1996; 5: 339-50.
13. Johnson J, Ostojic J, Lannfelt L, Glaser A, Basun H, Rogaeva E, et al. No evidence for tau duplications in frontal temporal dementia families showing genetic linkage to the tau locus in which tau mutations have not been found. Neurosci Lett 2004; 363: 99-101.
14. Josephs KA, Holton JL, Rossor MN, Godbolt AK, Ozawa T, Strand K, et al. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol 2004; 30: 369-73.
15. Kertesz A, Kawarai T, Rogaeva E, St George-Hyslop P, Poorkaj P, Bird TD, et al. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology 2000; 54: 818-27.
16. Kong X, Murphy K, Raj T, He C, White PS, Matise TC. A combined linkage-physical map of the human genome. Am J Hum Genet 2004; 75: 1143-8.
17. Kovari E, Leuba G, Savioz A, Saini K, Anastasiu R, Miklossy J. Familial frontotemporal dementia with ubiquitin inclusion bodies and without motor neuron disease. Acta Neuropathol (Berl) 2000; 100: 421-6.
18. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-7.
19. Lathrop GM, Lalouel JM. Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet 1984; 36: 460-5.
20. Lendon CL, Lynch T, Norton J, McKeel DW Jr, Busfield F, Cradock N, et al. Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21-22. Neurology 1998; 50: 1546-55.
21. Lipton AM, White CL 3rd, Bigio EH. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol (Berl) 2004; 108: 379-85.
22. Mackenzie IR, Feldman H. Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases. Acta Neuropathol (Berl) 2003; 105: 543-8.
23. Mackenzie IRA, Feldman H. Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum. J Neuropathol Exp Neurol 2005; 64: 730-9.
24. Mackenzie IR, Leavitt BR, Hutton ML. Genetics of FTD-MND type with neuronal intranuclear inclusions. Can J Neurol Sci 2004; 31: 586.
25. Mann DMA, McDonagh AM, Snowden JS, Neary D, Pickering-Brown SM. Molecular classification of the dementias. Lancet 2000; 355: 626-7.
26. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ; Work Group on Frontotemporal Dementia and Pick's Disease. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001; 58: 1803-9.
27. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-54.
28. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998; 43: 815-25.
29. Pountney DL, Huang Y, Burns RJ, Haan E, Thompson PD, Blumbergs PC, et al. SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Exp Neurol 2003; 184: 436-46.
30. Rademakers R, Cruts M, Dermaut B, Sleegers K, Rosso SM, Van den Broeck M, et al. Tau-negative frontal lobe dementia at 17q21: significant fine mapping of the candidate region to a 4.8-cm interval. Mol Psychiatry 2002; 7: 1064-74.
31. Rademakers R, Cruts M, van Broeckhoven C. The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum Mutat 2004; 24: 277-95.
32. Reed LA, Wszolek ZK, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Aging 2001; 22: 89-107.
33. Rosso SM, Kamphorst W, de Graaf B, Willemsen R, Ravid R, Niermeijer MF, et al. Familial frontotemporal dementia with ubiquitin-positive inclusions linked to chromosome 17q21-22. Brain 2001; 124: 1948-57.
34. Snowden JS, Neary D, Mann DMA. Frontotemporal lobar degeneration: frontotemporal dementia, progressive aphasia, semantic dementia. New York: Churchill-Livingstone; 1996.
35. Sobel E, Lange K. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker sharing statistics. Am J Hum Genet 1996; 58: 1323-37.
36. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multisystem tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998; 95: 7737-41.
37. Takahashi J, Fujigasaki H, Iwabuchi K, Bruni AC, Uchihara T, El Hachimi KH, et al. PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases. Neurobiol Dis 2003; 13: 230-7.
38. Taniguchi S, McDonagh AM, Pickering-Brown SM, Umeda Y, Iwatsubo T, Hasegawa M, et al. The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein. Neuropathol Appl Neurobiol 2004; 30: 1-18.
39. Terashima T, Kawai H, Fujitani M, Maeda K, Yasuda H. SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death. Neuroreport 2002; 13: 2359-64.
40. Woulfe J, Kertesz A, Munoz DG. Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions. Acta Neuropathol (Berl) 2001; 102: 94-102.
41. Zhukareva V, Vogelsberg-Ragaglia V, Van Deerlin VM, Bruce J, Shuck T, Grossman M, et al. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol 2001; 49: 165-75.
42. Zhukareva V, Sundarraj S, Mann D, Sjogren M, Blenow K, Clark CM, et al. Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study. Acta Neuropathol (Berl) 2003; 105: 469-76.